-
Nayax Announces Partnership with DKV Mobility to Expand Its Payments Capabilities Across Europe Fuel & service cards
24 Apr 2024 12:30 GMT
… ) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement … merchants scale their business, today announced a partnership with DKV Mobility …
-
Tower Semiconductor Announces First Quarter 2024 Financial Results and Conference Call
24 Apr 2024 07:00 GMT
MIGDAL HAEMEK, Israel – April 24, 2024 – Tower Semiconductor (NASDAQ/ TASE: TSEM), the leading foundry of high-value analog semiconductor solutions, will issue its first quarter 2024 earnings release on Thursday, May 9, 2024. The Company will hold a …
-
Jump Trading B.V. Europe, A Leading International Trading Firm, Joins Tel Aviv Stock Exchange As A Remote Member - As Of Today, Jump Trading Is Active On TASE
09 Apr 2024 17:40 GMT
TASE announces that today Jump Trading begins operating on TASE as a new remote … additional PoP between Frankfurt and TASE.
TASE has dedicated significant resources to … its broader strategy of aligning TASE with international standards, thereby facilitating …
-
Teva CEO Francis becomes highest paid TASE co exec
18 Apr 2024 12:05 GMT
… Teva Pharmaceutical Industries (NYSE: TEVA; TASE: TEVA) CEO Richard Francis totaled … highest paid among executives at Tel Aviv Stock Exchange listed companies. Nice Systems CEO … released as part of the announcement of Teva’s annual shareholders …
-
Kenon : Subsidiary OPC Energy Ltd. Announces Rejection of Plan to Construct a Power Plant on Land Adjacent to the Power Plant in Hadera
18 Apr 2024 07:38 GMT
… ;s Subsidiary OPC Energy Ltd. Announces Rejection of Plan to Construct … Ltd.'s (NYSE: KEN, TASE: KEN) ("Kenon") subsidiary … Ltd. ("OPC") has announced that on April 17, 2024 …
-
BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting
17 Apr 2024 14:00 GMT
… BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical … and rare diseases, today announced a poster presentation on … Ltd. (NASDAQ/TASE: BLRX) is a commercial … news-releases/biolinerx-announces-poster-presentation-on-apheresis- …
-
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
16 Apr 2024 21:30 GMT
… Ltd. (NYSE and TASE: TEVA), today announced that the U.S … added, “We are delighted to announce our second biosimilar approval in … 2023, Alvotech and Teva announced that they had reached a … Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global …
-
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
16 Apr 2024 21:55 GMT
… Ltd. (NYSE and TASE: TEVA), today announced that the U.S … added, “We are delighted to announce our second biosimilar approval in … 2023, Alvotech and Teva announced that they had reached a … Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global …
-
ICL Announces First Quarter 2024 Earnings Call
15 Apr 2024 12:14 GMT
… ICL) (TASE: ICL), a leading global specialty minerals company, today announced it … Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The company … .
Forward Looking Statements
This announcement contains statements that constitute forward …
-
BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024
24 Apr 2024 12:00 GMT
… ) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company … for mental health disorders, today announced that it will report its …